X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs AJANTA PHARMA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD AJANTA PHARMA ORCHID PHARMA LTD/
AJANTA PHARMA
 
P/E (TTM) x -0.6 20.7 - View Chart
P/BV x 0.5 8.9 5.1% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ORCHID PHARMA LTD   AJANTA PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
AJANTA PHARMA
Mar-16
ORCHID PHARMA LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1941,720 11.3%   
Low Rs351,103 3.2%   
Sales per share (Unadj.) Rs276.5194.6 142.1%  
Earnings per share (Unadj.) Rs-79.245.2 -175.2%  
Cash flow per share (Unadj.) Rs-43.550.3 -86.4%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs53.9132.0 40.9%  
Shares outstanding (eoy) m70.4588.77 79.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.47.3 5.7%   
Avg P/E ratio x-1.431.2 -4.6%  
P/CF ratio (eoy) x-2.628.1 -9.4%  
Price / Book Value ratio x2.110.7 19.9%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m8,067125,299 6.4%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5272,570 98.3%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,47717,275 112.7%  
Other income Rs m407166 244.9%   
Total revenues Rs m19,88417,442 114.0%   
Gross profit Rs m1,1035,807 19.0%  
Depreciation Rs m2,519451 559.1%   
Interest Rs m5,22749 10,688.8%   
Profit before tax Rs m-6,2365,474 -113.9%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1251,460 -8.6%   
Profit after tax Rs m-5,5804,014 -139.0%  
Gross profit margin %5.733.6 16.8%  
Effective tax rate %2.026.7 7.5%   
Net profit margin %-28.723.2 -123.3%  
BALANCE SHEET DATA
Current assets Rs m11,0147,639 144.2%   
Current liabilities Rs m32,0602,715 1,181.0%   
Net working cap to sales %-108.128.5 -379.1%  
Current ratio x0.32.8 12.2%  
Inventory Days Days9543 219.5%  
Debtors Days Days3479 42.7%  
Net fixed assets Rs m29,4406,914 425.8%   
Share capital Rs m705177 398.2%   
"Free" reserves Rs m2,04311,442 17.9%   
Net worth Rs m3,80011,721 32.4%   
Long term debt Rs m9,018149 6,064.5%   
Total assets Rs m46,51014,814 314.0%  
Interest coverage x-0.2112.9 -0.2%   
Debt to equity ratio x2.40 18,705.6%  
Sales to assets ratio x0.41.2 35.9%   
Return on assets %-0.827.4 -2.8%  
Return on equity %-146.934.2 -428.8%  
Return on capital %-3.746.5 -8.0%  
Exports to sales %37.955.1 68.7%   
Imports to sales %22.66.0 376.6%   
Exports (fob) Rs m7,3789,527 77.4%   
Imports (cif) Rs m4,4061,038 424.6%   
Fx inflow Rs m7,51310,422 72.1%   
Fx outflow Rs m5,6491,678 336.6%   
Net fx Rs m1,8658,744 21.3%   
CASH FLOW
From Operations Rs m1,6823,264 51.5%  
From Investments Rs m-9,860-2,093 471.1%  
From Financial Activity Rs m6,644-1,186 -560.3%  
Net Cashflow Rs m-1,535-15 10,371.6%  

Share Holding

Indian Promoters % 32.3 73.8 43.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 1.6 296.8%  
FIIs % 3.3 7.6 43.4%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 17.0 325.3%  
Shareholders   84,811 20,968 404.5%  
Pledged promoter(s) holding % 54.9 4.4 1,251.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   J.B.CHEMICALS  SUVEN LIFE  STERLING BIOTECH  CADILA HEALTHCARE  VENUS REMEDIES  

Compare ORCHID PHARMA LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 23, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - CADILA HEALTHCARE COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS